Burçin Tezcanlı Kaymaz
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 25, 2025
Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives.İlknur Karatekin Arik, Nurcan Gümüş, İlayda Alcitepe
|Apr 05, 2024
Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells.Burcin Tezcanli Kaymaz, Nurcan Gumus, Besne Celik
|Oct 12, 2022
HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents' combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model.İlayda Alcitepe, Hilal Salcin, İlknur Karatekin
Pageof 1